SCHEMBL9294669

SCHEMBL9294669

C#CC(C)(C)Oc1ccc(S(=O)(=O)c2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ HTT P42858 1/20 0.46
▸ HTR6 P50406 2/20 0.45
▸ PKM P14618 4/20 0.43
▸ HSD11B1 P28845 2/20 0.43
▸ ELANE P08246 2/20 0.42
▸ PPARA Q07869 2/20 0.42
▸ POLB P06746 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ GAA P10253 3/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ GLA P06280 1/20 0.38
▸ MMP2 P08253 1/20 0.38
▸ MMP8 P22894 1/20 0.38
▸ MMP12 P39900 1/20 0.38
▸ MMP13 P45452 1/20 0.38
▸ MMP14 P50281 1/20 0.38
▸ MMP16 P51512 1/20 0.38
▸ ABCC9 O60706 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8483651 0.82 KMT2A (0.54) SMN1; SMN2HTTPKMMAPTALDH1A1
SCHEMBL9195881 0.81 PTGS2 (0.41) SMN1; SMN2HTTELANEALDH1A1
SCHEMBL23075718 0.81 HTR6 (0.54) SMN1; SMN2HTTHTR6PKMHSD11B1
SCHEMBL18405594 0.80 CA4 (0.39) ELANEPPARAMAPTALDH1A1MEN1
SCHEMBL7826045 0.80 CA2 (0.51) HTTPOLBALDH1A1TSHR
SCHEMBL9534370 0.79 HTR6 (0.58) HTTHTR6HSD11B1POLBGAA
SCHEMBL5308750 0.78 LTA4H (0.47) SMN1; SMN2HTTPPARAALDH1A1MEN1
SCHEMBL9200789 0.77 LMNA (0.56) SMN1; SMN2HTTELANEMAPTALDH1A1
SCHEMBL22295587 0.77 HTT (0.62) SMN1; SMN2HTTHTR6PKMHSD11B1
SCHEMBL22295637 0.77 HTT (0.62) SMN1; SMN2HTTHTR6PKMHSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5364878-A Antiasthmatics; urogenital disorders HOECHST AKTIENGESELLSCHAFT (DE) 1994-11-15 — — US disclosed
EP-0351720-B1 Use of substituted 3,4-dihydro-2H-benzopyrans as medicaments against obstructive disorders of the lung HOECHST AG (DE) 1994-08-24 — — EP disclosed
EP-0560399-A1 Use of substituted 3,4-dihydro-2H-benzopyrans as medicament against disorders of the urethra HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-15 — — EP disclosed
US-5043344-A Unsaturated N-benzopyranyllactams HOECHST AKTIENGESELLSCHAFT (DE) 1991-08-27 — — US disclosed
EP-0351720-A2 Use of substituted 3,4-dihydro-2H-benzopyrans as medicaments against obstructive disorders of the lung HOECHST AKTIENGESELLSCHAFT (DE) 1990-01-24 — — EP disclosed
EP-0337179-A1 Unsaturated N-benzopyranyllactams HOECHST AKTIENGESELLSCHAFT (DE) 1989-10-18 — — EP disclosed
Send feedback